The Effectiveness of Prophylactic Inferior Vena Cava Filters in Trauma Patients

Haut, Elliott R.; García, Luis; Shihab, Hasan M; Brotman, Daniel J.; Stevens, Kent A.; Sharma, Ritu; Chelladurai, Yohalakshmi; Akande, Tokunbo O; Shermock, Kenneth M.; Kebede, Sosena; Segal, Jodi B; Singh, Sonal

doi:10.1001/jamasurg.2013.3970

Cited by 146 publications

(99 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Which patients will derive enough benefit from filter deployment to outweigh the long-term complications remains unclear. As a matter of fact, the initiation of anticoagulation in patients considered to have bleeding diathesis is actually safer than originally thought, as shown by different retrospective and prospective studies (16). In almost two-thirds of our patients, anticoagulation was prescribed before discharge, indicating that contraindication for anticoagulation (if present when filter was placed) had subsided.…”

Section: Discussionmentioning

confidence: 62%

Patterns of use and outcome of inferior vena cava filters in a tertiary care setting

Rottenstreich

Spectre

Roth

et al. 2015

European J of Haematology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 62%

Patterns of use and outcome of inferior vena cava filters in a tertiary care setting

Rottenstreich

Spectre

Roth

et al. 2015

European J of Haematology

View full text Add to dashboard Cite

show abstract

“…As such, there is an ongoing debate about the appropriateness of prophylactic IVCF placement in these high-risk patients. A recent review and meta-analysis found a decreased incidence of PE with prophylactic IVCF placement, although this was with low strength of evidence [35]. This meta-analysis included six studies to examine PE rates and only four studies to examine fatal PE.…”

Section: Research In Indicationsmentioning

confidence: 99%

Inferior Vena Cava Filters: Indications, Outcomes, and Evidence

Montgomery

Kaufman

2015

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Filter technology seems relatively stable, although absorbable devices are an area of investigational interest. The indications for filter placement remain controversial, with wide variations in adherence to guidelines, and relatively poor quality of data about the specific prophylactic indications of trauma or bariatric surgery. The outcomes of filters are not well-defined despite widespread clinical use, and good data remains difficult to obtain. Several larger database and institutional retrospective studies support the notions that while filters prevent pulmonary embolism, they may be associated with venous thrombotic complications. Some subsets of cancer patients may be at increased risk of these complications, but whether the filter or the underlying hypercoagulable state is the cause is not clear. Lastly, although the benefits of filter retrieval are widely assumed (but not proven), filter retrieval rates remain lower than expected. The single most influential factor in improving filter retrieval rates is dedicated follow-up with intent to retrieve the filter.

show abstract

“…LMWH has been demonstrated to be safe and effective in trauma patients and is the approach recommended by the East Surgical Group and the current ACCP guidelines [ 34 , 35 ]. In trauma patients at high risk of bleeding the placement of a removal IVC fi lter may be a suitable strategy [ 36 ].…”

Section: The Veins Of the Lower Limbmentioning

confidence: 99%

Venous Thromboembolic Disease: DVT and PE

Marik

2014

Evidence-Based Critical Care

View full text Add to dashboard Cite

Deep venous thrombosis (DVT) and pulmonary emboli (PE) are usually considered the same disease, namely, thromboembolic disease (TED), as a large proportion of patients with DVT have "asymptomatic" PE and about 40 % of patients with PE have "asymptomatic DVT". Furthermore, in most instances the treatment is the same. TED is a common disorder that carries a high mortality rate. In a population based study performed in Canada, Tagalakis and colleagues reported an incidence of venous thromboembolism of 0.90 per 1,000 person-years; the 30-day and 1-year case-fatality rates were 10.6 % and 23.0 % respectively [ 1 ]. The 1-year survival rate was 47 % in patients with cancer, 93 % in patients with unprovoked venous thromboembolism and 84 % in patients with venous thromboembolism secondary to a major risk factor. In this study 62 % of cases were associated with a major risk factor, with cancer, hospitalization, and surgery being the most common. In the International Cooperative Pulmonary Embolism Registry (ICOPER), all-cause mor ta lity rate at 3 month was 17 % [ 2 ]. PE was considered to be the cause of death in 45 % of patients. Important prognostic factors associated with death from pulmonary embolism were age older than 70 years, cancer, congestive heart failure, chronic obstructive pulmonary disease, systolic arterial hypotension, tachypnea, and right ventricular hypokinesis on echocardiography.

show abstract

The Effectiveness of Prophylactic Inferior Vena Cava Filters in Trauma Patients

Cited by 146 publications

References 43 publications

Patterns of use and outcome of inferior vena cava filters in a tertiary care setting

Patterns of use and outcome of inferior vena cava filters in a tertiary care setting

Inferior Vena Cava Filters: Indications, Outcomes, and Evidence

Venous Thromboembolic Disease: DVT and PE

Contact Info

Product

Resources

About